Development of Parkinson and Alzheimer Diseases in Two Cases of Narcolepsy-Cataplexy
- 1 January 2012
- journal article
- letter
- Published by S. Karger AG in European Neurology
- Vol. 67 (1), 48-50
- https://doi.org/10.1159/000334733
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?Brain, 2010
- Excessive Daytime Sleepiness in Parkinson’s Disease: Characteristics and DeterminantsEuropean Neurology, 2010
- Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsyNeurology, 2009
- Antiparkinsonian drug‐induced sleepiness: a double‐blind placebo‐controlled study of L‐dopa, bromocriptine and pramipexole in healthy subjectsBritish Journal of Clinical Pharmacology, 2009
- Hypocretin/orexin disturbances in neurological disordersSleep Medicine Reviews, 2009
- Hypocretin (orexin) loss in Parkinson's diseaseBrain, 2007
- How common are the “common” neurologic disorders?Neurology, 2007
- Parkinsonism with excessive daytime sleepinessZeitschrift für Neurologie, 2005
- Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson DiseaseJama-Journal Of The American Medical Association, 2002
- The effects of L‐dopa on excessive daytime sleepiness in narcolepsyNeurology, 1991